A Randomized, Controlled, Multicenter Vaccine Clinical Trial to Evaluate The Safety and Immunogenicity of Combined Immunization With sIPV and DTaP
Latest Information Update: 04 Aug 2021
At a glance
- Drugs DTaP vaccine (Primary) ; Poliovirus vaccine inactivated Intravacc/Sinovac/WHO (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors China National Biotec Group
Most Recent Events
- 19 Aug 2019 New trial record